EMEA-001786-PIP01-15-M02
Key facts
| Invented name |
Ervebo
|
| Active substance |
Ebola Zaire Vaccine (rVSV∆G-ZEBOV-GP, live)
|
| Therapeutic area |
Vaccines
|
| Decision number |
P/0429/2021
|
| PIP number |
EMEA-001786-PIP01-15-M02
|
| Pharmaceutical form(s) |
Solution for injection
|
| Condition(s) / indication(s) |
Prevention of Ebola virus disease
|
| Route(s) of administration |
Intramuscular use
|
| Contact for public enquiries |
Merck Sharp & Dohme (Europe) Inc.
E-mail: pip.information@merck.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|